Table 4.
Comparison of MetS and its individual criteria in low and high bilirubin groups at baseline and follow-up visit
| Variable | Low bilirubin group (0.01–0.09 mg/dl) | High bilirubin group (0.10–0.30 mg/dl) | χ2 | p value |
|---|---|---|---|---|
| Female | 29 (42.0) | 24 (38.7) | 0.149 | 0.699 |
| Male | 40 (58.0) | 38 (61.3) | ||
| Baseline MetS present | 40 (58.0) | 20 (32.3) | 8.698 | 0.003 |
| Free of MetS | 29 (42.0) | 42 (67.7) | ||
| Follow-up MetS present | 41 (60.3) | 20 (37.7) | 6.063 | 0.014 |
| Free of MetS | 27 (39.7) | 33 (62.3) | ||
| Baseline individual MetS criteria | ||||
| Blood pressure | ||||
| Present (n=35) | 20 (44.1) | 15 (28.3) | ||
| Free of (n=76) | 38 (55.9) | 38 (71.7) | 3.191 | 0.074 |
| Fasting glucose | ||||
| Present (n=46) | 28 (40.6) | 18 (29.0) | 1.911 | 0.167 |
| Free of (n=85) | 41 (59.4) | 44 (71.0) | ||
| Waist circumference | ||||
| Present (n=60) | 51 (73.9) | 29 (46.8) | 10.117 | 0.001 |
| Free of (n=51) | 18 (26.1) | 33 (53.2) | ||
| HDL levels | ||||
| Present (n=96) | 54 (78.3) | 42 (67.7) | 1.846 | 0.174 |
| Free of (n=35) | 15 (21.7) | 20 (32.3) | ||
| Triglyceride levels | ||||
| Present (n=57) | 37 (51.5) | 20 (37.7) | 6.065 | 0.014 |
| Free of (n=74) | 32 (48.5) | 42 (62.3) | ||
| Insulin resistance present (n=33) | 21 (30.4) | 12 (19.4) | 2.127 | 0.145 |
| No insulin resistance (n=98) | 48 (69.6) | 50 (80.6) | ||
| Follow-up individual MetS criteria | ||||
| Blood pressure | ||||
| Present (n=45) | 30 (44.1) | 15 (28.3) | 3.190 | 0.074 |
| Free of (n=76) | 38 (55.9) | 38 (71.7) | ||
| Fasting glucose | ||||
| Present (n=53) | 36 (52.9) | 17 (32.1) | 5.268 | 0.022 |
| Free of (n=68) | 32 (47.1) | 36 (67.9) | ||
| Waist circumference | ||||
| Present (n=66) | 43 (63.2) | 23 (43.4) | 4.728 | 0.030 |
| Free of (n=55) | 25 (36.8) | 30 (56.6) | ||
| HDL levels | ||||
| Present (n=87) | 51 (75.0) | 36 (67.9) | 0.738 | 0.390 |
| Free of (n=34) | 17 (25.0) | 17 (32.1) | ||
| Triglyceride levels | ||||
| Present (n=55) | 35 (51.5) | 20 (37.7) | 2.266 | 0.093 |
| Free of (n=66) | 33 (48.5) | 33 (62.3) | ||
| Insulin resistance present (n=49) | 32 (47.1) | 17 (32.1) | 2.775 | 0.096 |
| No insulin resistance (n=72) | 36 (52.9) | 36 (67.9) | ||
| Course of MetS | ||||
| Continued MetS at both visits | 36 (90.0) | 10 (66.7) | 4.340 | 0.037 |
| Reverse MetS at follow-up visit | 4 (10.0) | 5 (33.3) | ||
| Free of MetS at both visits | 23 (82.1) | 28 (71.8) | 0.960 | 0.327 |
| Newly developed MetS at follow-up visit | 5 (17.9) | 10 (28.2) | ||
Values are presented as number (%).
MetS, metabolic syndrome; HDL, high-density lipoprotein.
By Pearson chi-square analysis.